CRBP Earnings & Financial Statements
Corbus Pharmaceuticals Holdings, Inc.
$5.49
-$0.29(-5.02%)
36
Overall
60
Value
27
Tech
23
Quality
Market Cap
$111.79M
Volume
1.24M
52W Range
$6.06 - $20.56
Target Price
$35.89
CRBP earnings and financial statements: Corbus Pharmaceuticals Holdings, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
CRBP Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | - | - | - | - | $881.7K |
| Operating income | -$85.31M | -$48.72M | -$45.08M | -$39.84M | -$55.99M |
| EBITDA | -$78.30M | -$37.35M | -$39.34M | -$34.07M | -$54.35M |
| Net income | -$78.54M | -$40.21M | -$44.60M | -$42.35M | -$45.64M |
| EPS (diluted) | $-5.90 | $-3.68 | $-10.31 | $-10.15 | $-11.10 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $168.19M | $155.88M | $28.27M | $66.31M | $107.73M |
| Total liabilities | $20.69M | $13.45M | $35.18M | $33.32M | $38.62M |
| Shareholders’ equity | $147.50M | $142.43M | -$6.91M | $32.99M | $69.11M |
| Cash and equivalents | $28.49M | $17.20M | $13.72M | $17.00M | $25.01M |
| Long-term debt | - | $1.63M | $3.24M | $20.66M | $21.59M |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | -$64.49M | -$41.79M | -$36.10M | -$37.54M | -$48.18M |
| Capital expenditure | -$7.0K | - | - | -$13.4K | -$54.2K |
| Free cash flow | -$64.50M | -$41.79M | -$36.10M | -$37.56M | -$48.24M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CRBP | $5.49 | -5.0% | 1.24M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Corbus Pharmaceuticals Holdings, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW